{"id":621556,"date":"2018-11-12T04:35:11","date_gmt":"2018-11-12T04:35:11","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/"},"modified":"2018-11-12T04:35:11","modified_gmt":"2018-11-12T04:35:11","slug":"egypts-ibnsina-pharma-sarwa-capital-report-results","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/","title":{"rendered":"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results"},"content":{"rendered":"

<\/a> EARNINGS WATCH- Ibnsina Pharma reported a 26.6% y-o-y increase in net profit to EGP 113.2 mn in 3Q2018<\/strong>, according to the company\u2019s earnings release (pdf)<\/a>. Revenues grew 31.9% y-o-y during the quarter, coming in at nearly EGP 3.5 bn, with growth being driven by client pharmacies, the company said. \u201cManagement\u2019s long-term goal is for Ibnsina to become a leading healthcare supply business provider, and the path to doing so in a structured and profitable manner lies in fostering economies of scale,\u201d according to Co-CEO Omar Abdel Gawad. \u201cAs the company expanded its client book and distribution network during the period, Ibnsina Pharma was able to spread its costs over a wider revenue base. Management is confident that the controlled and reduced costs associated with increased operational scale, coupled with Ibnsina Pharma\u2019s other competitive advantages, will bring us closer to our long-term goals,\u201d he added.<\/p>\n

Sarwa Capital reported 3Q2018 net income of EGP 100.4 mn in its maiden earnings report<\/strong>, up 104% y-o-y, according to a press release (pdf)<\/a>. The structured finance player said its results \u201cshowcase the strong growth and diversified growth dynamics within the business. Going forward, we expect continued strength across our product lines, while keeping a close eye on the macroeconomic and monetary environments to ensure that we remain well positioned to achieve growth while maintaining our unrivalled credit quality and performance.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

EARNINGS WATCH- Ibnsina Pharma reported a 26.6% y-o-y increase in net profit to EGP 113.2 mn in 3Q2018, according to the company\u2019s earnings release (pdf). Revenues grew 31.9% y-o-y during the quarter, coming in at nearly EGP 3.5 bn, with growth being driven by client pharmacies, the company said. \u201cManagement\u2019s long-term goal is for Ibnsina […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[933,302,72,1414,11917,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-621556","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-contact-financial","tag-earnings","tag-enterpriseam","tag-ibnsina-pharma","tag-omar-abdel-gawad","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"c6828149-4276-4af1-bd6a-10aaffdcd392","order":"0","is_powered_by":true,"section_story_id":"a15c2e1a-a0ba-4774-adfd-bc946bc3f9e7","story_type":"1","photo_url":"","photo_position":"above","related_issue":[621540],"teaser":"","voice_url":""},"yoast_head":"\nEgypt\u2019s Ibnsina Pharma, Sarwa Capital report results - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results\" \/>\n<meta property=\"og:description\" content=\"EARNINGS WATCH- Ibnsina Pharma reported a 26.6% y-o-y increase in net profit to EGP 113.2 mn in 3Q2018, according to the company\u2019s earnings release (pdf). Revenues grew 31.9% y-o-y during the quarter, coming in at nearly EGP 3.5 bn, with growth being driven by client pharmacies, the company said. \u201cManagement\u2019s long-term goal is for Ibnsina […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-12T04:35:11+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results\",\"datePublished\":\"2018-11-12T04:35:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\"},\"wordCount\":230,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"Contact Financial\",\"earnings\",\"EnterpriseAM\",\"Ibnsina Pharma\",\"Omar Abdel Gawad\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\",\"name\":\"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2018-11-12T04:35:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/","og_locale":"en_US","og_type":"article","og_title":"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results","og_description":"EARNINGS WATCH- Ibnsina Pharma reported a 26.6% y-o-y increase in net profit to EGP 113.2 mn in 3Q2018, according to the company\u2019s earnings release (pdf). Revenues grew 31.9% y-o-y during the quarter, coming in at nearly EGP 3.5 bn, with growth being driven by client pharmacies, the company said. \u201cManagement\u2019s long-term goal is for Ibnsina […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2018-11-12T04:35:11+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results","datePublished":"2018-11-12T04:35:11+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/"},"wordCount":230,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["Contact Financial","earnings","EnterpriseAM","Ibnsina Pharma","Omar Abdel Gawad","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/","url":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/","name":"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2018-11-12T04:35:11+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2018\/11\/12\/egypts-ibnsina-pharma-sarwa-capital-report-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Egypt\u2019s Ibnsina Pharma, Sarwa Capital report results"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":625744,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/08\/14\/earnings-watch-ibnsina-pharma-acc-te-report-1h2018-results\/","url_meta":{"origin":621556,"position":0},"title":"Earnings Watch: Ibnsina Pharma, ACC, TE report 1H2018 results","author":"enterpriseam admin","date":"14 August 2018","format":false,"excerpt":"EARNINGS WATCH- Ibnsina Pharma reported a 40.1% y-o-y increase in net profit to EGP 75.2 mn in 1H2018, according to the company\u2019s earnings release (pdf). Revenues grew 46% y-o-y during the six month period, coming in at nearly EGP 6 bn, \u201cdriven by double-digit expansion across all business lines,\u201d according\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":595825,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/08\/07\/earnings-watch-ibnsina-pharma\/","url_meta":{"origin":621556,"position":1},"title":"Earnings watch: Ibnsina Pharma","author":"enterpriseam admin","date":"7 August 2019","format":false,"excerpt":"EARNINGS WATCH- Ibnsina Pharma\u2019s 2Q2019 profits surge 26% y-o-y: Ibnsina Pharma reported a 26% y-o-y increase in consolidated net profits to EGP 60.5 mn in 2Q2019, up from EGP 48 mn last year, the company said in a statement (pdf). Revenues rose 24% y-o-y to EGP 3.9 bn. The company\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":622467,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/10\/02\/ibnsina-pharmas-omar-abdel-gawad-is-at-his-desk-today\/","url_meta":{"origin":621556,"position":2},"title":"Ibnsina Pharma\u2019s Omar Abdel Gawad is at his desk today","author":"enterpriseam admin","date":"2 October 2018","format":false,"excerpt":"Much ado about nothing: Ibnsina Pharma co-CEO Omar Abdel Gawad is at his desk today. That\u2019s the take-home message from the EGX-listed pharma distributor after news reports yesterday reporting that a senior manager of Ibnsina Pharma had been detained in connection with an ongoing antitrust case before the Cairo Economic\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":631605,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","url_meta":{"origin":621556,"position":3},"title":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years","author":"enterpriseam admin","date":"22 March 2018","format":false,"excerpt":"INVESTMENT WATCH- Ibnsina Pharma is looking to invest EGP 150-200 mn over the next five years to increase its market share to 26% from a current 19.3%, Managing Director Omar Abdel Gawad tells Al Mal. The new funds would bring the company\u2019s total investments to EGP 700 mn, a target\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":628836,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/05\/15\/earnings-watch-efg-hermes-ibnsina-pharma-oriental-weavers-arabian-cement-global-telecom-faisal-islamic-bank-report-1q2018-results\/","url_meta":{"origin":621556,"position":4},"title":"Earnings Watch: EFG Hermes, Ibnsina Pharma, Oriental Weavers, Arabian Cement, Global Telecom, Faisal Islamic Bank report 1Q2018 results","author":"enterpriseam admin","date":"15 May 2018","format":false,"excerpt":"EARNINGS WATCH- EFG Hermes reported a net profit after tax and minority interest of EGP 249 mn in 1Q2018, marking a 6% y-o-y increase \u201cwhen adjusting for one-off gains related to the sale of our stake in Lebanese bank Credit Libanais in the comparable period last year.\u201d Revenues also increased\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":573721,"url":"https:\/\/enterpriseam.com\/egypt\/2020\/08\/16\/prime-holding-reports-egp-18-mn-loss-arabian-cement-reports-egp-5-64-loss-for-1h2020-ibnsina-pharma-reports-16-growth-in-revenues\/","url_meta":{"origin":621556,"position":5},"title":"Prime Holding reports EGP 18 mn loss, Arabian Cement reports EGP 5.64 loss for 1H2020, Ibnsina Pharma reports 16% growth in revenues","author":"enterpriseam admin","date":"16 August 2020","format":false,"excerpt":"EARNINGS WATCH- Ibnsina Pharma\u2019s net profits dipped 36.8% y-o-y to EGP 38.7 mn in 2Q2020, from EGP 62.2 mn in 2Q2019, according to the company\u2019s earnings release (pdf). Ibnsina reported EGP 4.4 bn in revenues during the quarter, up 16% y-o-y from EGP 3.82 bn. In the first half of\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/621556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=621556"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/621556\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/621540"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=621556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=621556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=621556"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=621556"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=621556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}